UPC CoA 19/2026

The Court of Appeal rejected Guardant's appeal against the Paris Local Division's refusal of provisional measures, finding the appeal largely unsuccessful. The CoA partly set aside the CFI's order by increasing the interim costs award to EUR 300,000, declared Sophia's cross-appeal inadmissible, and ordered Guardant to bear the costs of both first-instance and appeal proceedings.

The Court of Appeal (Panel 2: Kalden, Rombach, Simonsson) rejected Guardant Health's application for suspensive effect regarding the Paris Local Division's interim award of costs of EUR 400,000 ordered against Guardant following the rejection of its application for provisional measures concerning EP 3 443 066 (one of four patents originally asserted). The court found no manifest error in the CFI's interim costs award and dismissed the application. Sophia's request to set a payment deadline was also considered.